What to expect when you take Cephalexin and have Paralytic ileus?

Do you take Cephalexin and have Paralytic ileus? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Sep, 19, 2018

3,146 reports have been studied.


Females aged 50 to 59 :

2,026 related reports were analyzed:

Most common symptoms:

Abdominal pain
  • 7.16% for females aged 50 (±5) who take Cephalexin
Anaemia
  • 11.75% for females aged 50 (±5) who take Cephalexin
Anhedonia
  • 5.43% for females aged 50 (±5) who take Cephalexin
Appetite - decreased
  • 5.97% for females aged 50 (±5) who take Cephalexin
Back pain
  • 12.24% for females aged 50 (±5) who take Cephalexin
Bone disorder
  • 9.92% for females aged 50 (±5) who take Cephalexin
Bone lesion
  • 5.13% for females aged 50 (±5) who take Cephalexin
Bone pain
  • 6.27% for females aged 50 (±5) who take Cephalexin
Chest pain
  • 7.8% for females aged 50 (±5) who take Cephalexin
Constipation
  • 6.86% for females aged 50 (±5) who take Cephalexin
Cough
  • 6.17% for females aged 50 (±5) who take Cephalexin
Deformity
  • 5.53% for females aged 50 (±5) who take Cephalexin
Dehydration
  • 5.73% for females aged 50 (±5) who take Cephalexin
Depression
  • 10.71% for females aged 50 (±5) who take Cephalexin
Diarrhea
  • 11.94% for females aged 50 (±5) who take Cephalexin
Dizziness
  • 9.67% for females aged 50 (±5) who take Cephalexin
Drug hypersensitivity
  • 6.42% for females aged 50 (±5) who take Cephalexin
Dyspnea
  • 12.19% for females aged 50 (±5) who take Cephalexin
Emotional distress
  • 9.08% for females aged 50 (±5) who take Cephalexin
Exostosis
  • 6.17% for females aged 50 (±5) who take Cephalexin
Fall
  • 9.87% for females aged 50 (±5) who take Cephalexin
Fatigue
  • 12.54% for females aged 50 (±5) who take Cephalexin
Fever
  • 10.86% for females aged 50 (±5) who take Cephalexin
Gait disturbance
  • 6.52% for females aged 50 (±5) who take Cephalexin
Gastroesophageal reflux disease
  • 8.88% for females aged 50 (±5) who take Cephalexin
Headache
  • 9.28% for females aged 50 (±5) who take Cephalexin
High blood pressure
  • 8.09% for females aged 50 (±5) who take Cephalexin
Hypoaesthesia
  • 11.85% for females aged 50 (±5) who take Cephalexin
Impaired healing
  • 5.48% for females aged 50 (±5) who take Cephalexin
Injury
  • 10.86% for females aged 50 (±5) who take Cephalexin
Insomnia
  • 6.91% for females aged 50 (±5) who take Cephalexin
Intervertebral disc protrusion
  • 6.61% for females aged 50 (±5) who take Cephalexin
Joint pain
  • 11.45% for females aged 50 (±5) who take Cephalexin
Metastases to bone
  • 6.86% for females aged 50 (±5) who take Cephalexin
Nausea
  • 15.4% for females aged 50 (±5) who take Cephalexin
Nausea and vomiting
  • 8.59% for females aged 50 (±5) who take Cephalexin
Neuropathy peripheral
  • 7.7% for females aged 50 (±5) who take Cephalexin
Oedema peripheral
  • 8.64% for females aged 50 (±5) who take Cephalexin
Osteoarthritis
  • 10.81% for females aged 50 (±5) who take Cephalexin
Osteomyelitis
  • 6.17% for females aged 50 (±5) who take Cephalexin
Osteonecrosis of jaw
  • 11.9% for females aged 50 (±5) who take Cephalexin
Osteoporosis
  • 6.12% for females aged 50 (±5) who take Cephalexin
Pain
  • 20.34% for females aged 50 (±5) who take Cephalexin
Pain in extremity
  • 10.71% for females aged 50 (±5) who take Cephalexin
Pain in jaw
  • 7.45% for females aged 50 (±5) who take Cephalexin
Paraesthesia
  • 7.6% for females aged 50 (±5) who take Cephalexin
Pleural effusion
  • 5.73% for females aged 50 (±5) who take Cephalexin
Pneumonia
  • 7.7% for females aged 50 (±5) who take Cephalexin
Rashes
  • 9.38% for females aged 50 (±5) who take Cephalexin
Sinusitis
  • 5.53% for females aged 50 (±5) who take Cephalexin
Spinal osteoarthritis
  • 8.05% for females aged 50 (±5) who take Cephalexin
Stress and anxiety
  • 19.79% for females aged 50 (±5) who take Cephalexin
Swallowing difficulty
  • 6.86% for females aged 50 (±5) who take Cephalexin
Swelling
  • 6.76% for females aged 50 (±5) who take Cephalexin
Tooth abscess
  • 7.06% for females aged 50 (±5) who take Cephalexin
Tooth extraction
  • 5.33% for females aged 50 (±5) who take Cephalexin
Tooth loss
  • 7.35% for females aged 50 (±5) who take Cephalexin
Urinary tract infection
  • 9.03% for females aged 50 (±5) who take Cephalexin
Weakness
  • 13.18% for females aged 50 (±5) who take Cephalexin
Weight decreased
  • 7.01% for females aged 50 (±5) who take Cephalexin

Most common co-existing conditions:

Breast cancer
  • 6.02% for females aged 50 (±5) who take Cephalexin
Depression
  • 5.77% for females aged 50 (±5) who take Cephalexin
High blood pressure
  • 6.47% for females aged 50 (±5) who take Cephalexin
Multiple sclerosis
  • 5.48% for females aged 50 (±5) who take Cephalexin
Pain
  • 8.34% for females aged 50 (±5) who take Cephalexin
Rheumatoid arthritis
  • 6.02% for females aged 50 (±5) who take Cephalexin
back to top

Males aged 50 to 59 :

1,120 related reports were analyzed:

Most common symptoms:

Anaemia
  • 6.43% for males aged 50 (±5) who take Cephalexin
Atelectasis
  • 5.18% for males aged 50 (±5) who take Cephalexin
Back pain
  • 6.88% for males aged 50 (±5) who take Cephalexin
Bone disorder
  • 5.8% for males aged 50 (±5) who take Cephalexin
Chest pain
  • 6.7% for males aged 50 (±5) who take Cephalexin
Constipation
  • 5.0% for males aged 50 (±5) who take Cephalexin
Cough
  • 5.63% for males aged 50 (±5) who take Cephalexin
Dehydration
  • 5.71% for males aged 50 (±5) who take Cephalexin
Depression
  • 9.02% for males aged 50 (±5) who take Cephalexin
Diarrhea
  • 6.07% for males aged 50 (±5) who take Cephalexin
Dizziness
  • 5.98% for males aged 50 (±5) who take Cephalexin
Dyspnea
  • 7.68% for males aged 50 (±5) who take Cephalexin
Fall
  • 5.45% for males aged 50 (±5) who take Cephalexin
Fatigue
  • 12.32% for males aged 50 (±5) who take Cephalexin
Fever
  • 8.48% for males aged 50 (±5) who take Cephalexin
Gastroesophageal reflux disease
  • 6.79% for males aged 50 (±5) who take Cephalexin
Headache
  • 7.32% for males aged 50 (±5) who take Cephalexin
High blood pressure
  • 7.14% for males aged 50 (±5) who take Cephalexin
Injury
  • 7.77% for males aged 50 (±5) who take Cephalexin
Insomnia
  • 6.52% for males aged 50 (±5) who take Cephalexin
Itching
  • 6.07% for males aged 50 (±5) who take Cephalexin
Joint pain
  • 7.05% for males aged 50 (±5) who take Cephalexin
Nausea
  • 10.36% for males aged 50 (±5) who take Cephalexin
Nausea and vomiting
  • 7.32% for males aged 50 (±5) who take Cephalexin
Oedema
  • 5.09% for males aged 50 (±5) who take Cephalexin
Oedema peripheral
  • 6.88% for males aged 50 (±5) who take Cephalexin
Osteomyelitis
  • 5.0% for males aged 50 (±5) who take Cephalexin
Osteonecrosis of jaw
  • 5.98% for males aged 50 (±5) who take Cephalexin
Pain
  • 14.2% for males aged 50 (±5) who take Cephalexin
Pain in extremity
  • 5.36% for males aged 50 (±5) who take Cephalexin
Pleural effusion
  • 6.16% for males aged 50 (±5) who take Cephalexin
Pneumonia
  • 5.45% for males aged 50 (±5) who take Cephalexin
Rashes
  • 10.18% for males aged 50 (±5) who take Cephalexin
Stress and anxiety
  • 16.25% for males aged 50 (±5) who take Cephalexin
Thrombocytopenia
  • 5.18% for males aged 50 (±5) who take Cephalexin
Weakness
  • 8.21% for males aged 50 (±5) who take Cephalexin
Weight decreased
  • 5.0% for males aged 50 (±5) who take Cephalexin

Most common co-existing conditions:

High blood pressure
  • 6.7% for males aged 50 (±5) who take Cephalexin
Pain
  • 7.86% for males aged 50 (±5) who take Cephalexin
back to top

Related studies

cephalexin

Cephalexin has active ingredients of cephalexin. It is often used in infection. (latest outcomes from Cephalexin 14,321 users)

paralytic ileus

Paralytic ileus (intestinal obstruction) has been reported by people with crohn's disease, acne, high blood pressure, pain (latest reports from 33,521 Paralytic ileus patients).

Cephalexin and Paralytic ileus

Related publications that referenced our studies


Analysis tools (to study 506 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Cephalexin, Paralytic ileus

Recent updates

General studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.